Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. - sprookjes - yvandenbroek - TriplyDB

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

http://www.wikidata.org/entity/Q48819704

about

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process Advanced MRI and staging of multiple sclerosis lesions MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update.Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis "Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine Spring cleaning: time to rethink imaging research lines in MS?FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.Insights from Ultrahigh Field Imaging in Multiple Sclerosis.Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.Spatiotemporal evolution of venous narrowing in acute MS lesions.Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease.Key clinical benefits of neuroimaging at 7T.The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study.The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD

P2860

Q26796643-C6518993-E517-4539-AAF0-E2F889BD5B2B Q29542960-F0FB0B0F-1B89-499C-884A-BFBEDE162A23 Q30825494-D7568C24-9C62-44A1-BB39-6A5259CBA076 Q30981999-7F6B9B78-7AB9-46DB-A30F-029FE478B83D Q31015218-ADDF6A20-1B18-4A9C-96B1-9AD9E9A376BA Q34203136-03E86DB8-004A-466B-AD73-5C5CF0DCD6CF Q36565226-063DB1D7-7B8E-465C-A70F-658F1D35193A Q38737202-CA67A5B9-AF36-4C61-8DA8-8825B1FE1EFA Q38930555-7E60E42E-29CC-49F9-BCCB-61513B07FF12 Q39013846-62FD629E-A7AD-439E-A4CB-651D487DE6BA Q39229796-57342E46-3439-471A-AFB1-2718B5DCB879 Q40220046-0B55AB1B-5F57-43C3-8F83-1AECC25D35E1 Q41654013-DFF695C1-DFD9-4C2A-A4E9-E8D53A679E95 Q45961588-255E4A16-B2A4-42A7-A6BB-C26384032DF0 Q47845780-57AC12AC-7F8D-4AD4-8ED6-1DA9F6EBDDE9 Q47868081-E9452762-E9B9-47C5-93AE-2AC50143EF9F Q48168382-273973E2-4253-4BD2-B67C-06CD4B31075E Q48402350-1C1CC4E9-9713-49ED-AFF8-10F2802F5312 Q48428333-01040F94-BC92-4941-BEFD-AF82453F3F4E Q48678554-C0EEFB36-8668-44A0-B14B-54DE53D102C5 Q52560368-0F206E12-CF2C-4B4A-8453-E8436B1BF25E Q52874543-2C618DEC-4163-4ED9-AE80-426345F5464E Q57821323-7B698730-359C-4C97-8440-50DA5309BDE3

P2860

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

http://www.wikidata.org/entity/Q48819704

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@en

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@nl

type

label

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@en

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@nl

prefLabel

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@en

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@nl

P1433

Q48819704-F2FB2AD2-D45C-4916-8205-039DCBF2298A

P1476

Q48819704-3306BD6B-9230-4A0F-9DE2-D64C8AB2E3D5

P2093

Q48819704-3E25A434-31E2-425D-8319-CAD1D52AD12A

Q48819704-431FC129-0ABF-4557-8C21-2C5635D0A39A

Q48819704-52B3CE5D-BBE9-4F53-B804-7636054F3CDB

Q48819704-5B40CE3F-2B79-48D5-BA7E-84D6CDD845A0

Q48819704-7EBA9205-20A8-43AC-B853-D20FE2D23B83

Q48819704-808870A6-3C82-456F-BC36-0695430D7F9B

Q48819704-8561098A-1497-4828-AEAF-3CB2EFE0CFD0

Q48819704-8C621BB8-68F0-4D88-A031-4953EEFF198C

Q48819704-D7AE5B71-5043-4EDE-A160-764E72E72B1E

Q48819704-E5D9F208-A525-46BE-B4A1-461ABD0E4593

P2860

Q48819704-1BAB7463-F515-4857-9E2D-D4D6009A7332

Q48819704-22B6F19D-EAE6-46E0-8F1C-9327CE3BC917

Q48819704-25CD18F5-08EE-4D61-93EA-09AD2811D74A

Q48819704-3B2BFC5D-3F8D-4B5C-8974-243718B0B6CB

Q48819704-3E775DCE-4C61-4DDC-B94E-7C7EF7C51483

Q48819704-45CDF34A-A918-4D08-83BD-043DD1FF10E4

Q48819704-5579B6D5-8961-4054-9DCF-F0585883B7EB

Q48819704-5BC8332A-0D0B-426B-9619-A90B8DEEB420

Q48819704-65CFB379-207C-4D83-AC0F-6950DD451074

Q48819704-68536745-6FF3-4C3C-92AC-948A9D283301

P2888

Q48819704-9D26D507-4144-4582-A24C-848CE23C8265

P304

Q48819704-F892CA36-3030-4E7C-9C3B-A048E7F554FE

P31

Q48819704-5717802A-5B9D-4178-97BD-DDEAB6A6BBA1

P356

Q48819704-35A0D8C9-D2C5-48F9-9F6D-0B7F251A00DE

P407

Q48819704-E254EC28-5756-4B42-983B-566840233F9F

P433

Q48819704-B2127356-89BD-4BF9-8EA6-2A02F437546D

P478

Q48819704-A1FAF101-80B9-4F0E-8CA1-828183FB3F82

P50

Q48819704-D16F07C5-2C45-4F2D-B841-E4ED192E4AC5

P577

Q48819704-08BBDF16-4AC2-44EC-8912-80A56EF30D34

P698

Q48819704-4553D367-002E-4258-9143-F4689FEB172B

P356

S00330-013-3080-Y

P1433

European Radiology

P1476

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

@en

P2093

Alexandra Lopez-Soriano

http://www.w3.org/2001/XMLSchema#string

Chris H Polman

http://www.w3.org/2001/XMLSchema#string

Iris D Kilsdonk

http://www.w3.org/2001/XMLSchema#string

Jeroen J G Geurts

http://www.w3.org/2001/XMLSchema#string

Joost P A Kuijer

http://www.w3.org/2001/XMLSchema#string

Mandy M A Conijn

http://www.w3.org/2001/XMLSchema#string

Marcus C de Jong

http://www.w3.org/2001/XMLSchema#string

Mike P Wattjes

http://www.w3.org/2001/XMLSchema#string

Mirjam I Geerlings

http://www.w3.org/2001/XMLSchema#string

Peter R Luijten

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.

FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

MRI assessment of iron deposition in multiple sclerosis.

P2888

s00330-013-3080-y

P304

841-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-013-3080-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Frederik Barkhof

P577

2013-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24317461

http://www.w3.org/2001/XMLSchema#string